Medicago

Medicago has developed a breakthrough therapeutic protein manufacturing system, ProficiaTM, that can greatly improve the cost and accessibility of today's emerging biotherapeutics for both partners and patients. Medicago's safe and versatile ProficiaTM system is fuelling multiple product developments programs for biotechnology and pharmaceutical partners as well as the company's own proprietary pipeline of products

Contact Details: 1020, route de l'Église, bureau 600 Québec Quebec G1V 3V9 Canada Tel: 418 658.9393 Fax: 418 658.6699 Email: info@medicago.com WWW: www.medicago.com/

Loading...

Recent Publications by Medicago:
Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. A strain-specific vaccine represents the best possible response to the...	29th July, 2009	Medicago Inc., 1020 Route de l'Eglise, Bureau 600, Quebec, QC, Canada, G1V	Plant Biotechnol J. 2008 Dec;6(9):930-40. DOI Direct Link
Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant-based transient expression is potentially the most rapid and...	26th June, 2009	Medicago	Plant Biotechnol J. 2009 Jun;7(5):442-55. DOI Direct Link
Transient expression of antibodies in plants using syringe agroinfiltration. The improvements in agroinfiltration methods for plant-based transient...	20th February, 2009	Medicago inc., Quebec, QC, Canada.	Methods Mol Biol. 2009;483:41-50. DOI Direct Link
Plant N-glycan profiling of minute amounts of material. Development of convenient strategies for identification of plant N-glycan...	7th October, 2008	CNRS-FRE 3090, IFRMP 23, Universite de Rouen, 76821 Mont Saint Aignan	Anal Biochem. 2008 Aug 1;379(1):66-72. Epub 2008 Apr 25. DOI Direct Link

Press Releases on Medicago:
Medicago to present at the U.S. Department of Health and Human Services' Global Health Security Initiative Workshop	4th November, 2009	Medicago Inc.	QUEBEC CITY, Nov. 4 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing
Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy	8th October, 2009	Medicago Inc.	QUEBEC CITY, Oct. 8 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing
Medicago begins human clinical testing with its avian flu pandemic vaccine	1st October, 2009	Medicago Inc.	QUEBEC CITY, Oct. 1 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing
Medicago's H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose	30th July, 2009	Medicago Inc.	QUEBEC CITY, July 30 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing
Medicago succesfully expresses VLP antigen for A H1N1 strain	12th May, 2009	Medicago Inc.	QUEBEC CITY, May 12 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing

BioNews Results for Medicago:
Medicago announces filing of final short form prospectus	Yahoo! Canada:  Nov 20 2009 5:31AM Matching: medicago
Medicago announces filing of preliminary short form prospectus	Yahoo! Canada:  Nov 12 2009 11:57PM Matching: medicago
An expression database for roots of the model legume Medicago truncatula under salt stress	Bioscience Technology Online:  Nov 13 2009 12:18PM Matching: medicago
Medicago to present at the U.S. Department of Health and Human Services' Global Health Security Initiative Wor	PR Newswire:  Nov 8 2009 5:58PM Matching: medicago
Medicago announces $10,080,000 bought deal equity financing	Yahoo! Canada:  Nov 6 2009 4:32PM Matching: medicago
Promote your company here: BioNewsCast - Press Release Distribution	→View more Medicago news.

Medicago Patents:
US Patent No.	Title
7125978	Promoter for regulating expression of foreign genes
6420548	Method for regulating transcription of foreign genes

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 218 times since April 2007, the link to the organisation's website has been followed 43 times

Search for more companies in Québec

Search for more companies in Quebec

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Medicago